JHL-1155

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameJHL-1155
Drug Alias Nameanti-CTLA4 fully human monoclonal antibody (JHL Biotech/HumOrigin)CTLA-4 checkpoint inhibitor (HumOrigin/JHL Biotech)JHL-1155
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHumOrigin Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHumOrigin IncEden Biologics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A